These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 22391988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.
    Zhang R, Haverich A, Strüber M, Simon A, Pichlmaier M, Bara C.
    Clin Res Cardiol; 2008 Nov; 97(11):811-9. PubMed ID: 18648727
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
    Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Buss S, Hardt S, Sack FU, Katus HA, Dengler TJ.
    Transplantation; 2009 Sep 27; 88(6):835-41. PubMed ID: 19920784
    [Abstract] [Full Text] [Related]

  • 5. Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.
    Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA.
    Drug Des Devel Ther; 2013 Sep 27; 7():1323-8. PubMed ID: 24235815
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of oral ivabradine as a heart rate-reducing agent in patients undergoing CT coronary angiography.
    Adile KK, Kapoor A, Jain SK, Gupta A, Kumar S, Tewari S, Garg N, Goel PK.
    Br J Radiol; 2012 Aug 27; 85(1016):e424-8. PubMed ID: 22815422
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapy.
    Celik O, Atasoy MM, Ertürk M, Yalçın AA, Aksu HU, Diker M, Aktürk IF, Atasoy I.
    Acta Radiol; 2014 Jul 27; 55(6):676-81. PubMed ID: 24052362
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
    Kaplinsky E, Comes FP, Urondo LS, Ayma FP.
    Cardiol J; 2010 Jul 27; 17(2):166-71. PubMed ID: 20544616
    [Abstract] [Full Text] [Related]

  • 13. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK.
    J Cardiovasc Pharmacol Ther; 2013 Jul 27; 18(4):338-44. PubMed ID: 23426376
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Adler A, Rosso R, Meir I, Viskin S.
    Europace; 2013 Mar 27; 15(3):362-5. PubMed ID: 23118003
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
    Xu X, Guo Y, Gao W, Huang M, Liu T, Li F.
    Eur J Pediatr; 2023 May 27; 182(5):2265-2271. PubMed ID: 36869903
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP.
    J Am Coll Cardiol; 2012 Oct 09; 60(15):1323-9. PubMed ID: 22981555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.